homefeedbacksupportlog on 20-Aug-2008 
  Search
 
   
 
  Browse
ALL OF MEDICINE

ONCOLOGY
Breast Diseases: Benign & Malignant
Cancer in the Elderly
Genitourinary Cancers
Gynecological Cancers
Head & Neck Cancers
Oncology Agents
Pediatric Oncology
Sarcomas
Supportive & Palliative Cancer Care
Related Sections
Adrenal Cortex
Gastrointestinal Cancers
Leukemia & Proliferative Disorders of Hematic Cells
Lung Cancer
Lymphomas & Myelomas
Multiple Endocrine Disorders & Neoplasias
Neuro-Oncology
Skin Cancers (Inc. Melanoma & Lymphoma)

profile subject selected for My F1000 Medicine

Browse > ONCOLOGY > Breast Diseases: Benign & Malignant
Current Top 10 by F1000 Factor / All Time Top 10 by F1000 Factor / Most viewed
(from all journals) / Most viewed
(from specialty journals) / Hidden jewels		Page 1 of 6. Select Page: 1 2 3 4 5 6 >>
Display 10 / 20 / 50 papers per page

printer friendly 
to email [Help]

Must Read
F1000 Factor 6.0

Confirmation
 Proportion of Invasive Breast Cancer Attributable to Risk Factors Modifiable after Menopause.
Sprague BL, Trentham-Dietz A, …, Hampton JM, Newcomb PA
Am J Epidemiol 2008 Jun 13 [abstract on PubMed] [related articles] [full text]
Selected by | JoAnn Manson
Evaluated 8 Aug 2008

Recommended
F1000 Factor 3.0

Hypothesis
 Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk.
Gail MH
J Natl Cancer Inst 2008 Jul 16 100(14):1037-41 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Paul Terry with Pamela Mink
Evaluated 24 Jul 2008

Exceptional
F1000 Factor 9.0

Tech Advance
 Short preoperative treatment with erlotinib inhibits tumor cell proliferation in hormone receptor-positive breast cancers.
Guix M, Granja Nde M, …, Kelley MC, Arteaga CL
J Clin Oncol 2008 Feb 20 26(6):897-906 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | David Potter
Evaluated 24 Jul 2008

Recommended
F1000 Factor 3.0

Confirmation
 Incomplete pregnancy is not associated with breast cancer risk: the California Teachers Study.
Henderson KD, Sullivan-Halley J, …, Ursin G, Bernstein L
Contraception 2008 Jun 77(6):391-6 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Margaret Rees
Evaluated 22 Jul 2008

Recommended
F1000 Factor 3.0

New Finding
 The effect of mifepristone on breast cell proliferation in premenopausal women evaluated through fine needle aspiration cytology.
Engman M, Skoog L, Söderqvist G, Gemzell-Danielsson K
Hum Reprod 2008 Jun 24 [abstract on PubMed] [related articles] [full text]
Selected by | Alistair Williams
Evaluated 21 Jul 2008

Must Read
F1000 Factor 6.0

Hypothesis
 Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer.
Musolino A, Naldi N, …, Neri TM, Ardizzoni A
J Clin Oncol 2008 Apr 10 26(11):1789-96 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Christos Sotiriou with Michail Ignatiadis
Evaluated 17 Jul 2008

Recommended
F1000 Factor 3.0

New Finding
Controversial
 Bisphenol A induces a profile of tumor aggressiveness in high-risk cells from breast cancer patients.
Dairkee SH, Seok J, …, Davis RW, Goodson WH
Cancer Res 2008 Apr 1 68(7):2076-80 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Ruth Keri
Evaluated 15 Jul 2008

Must Read
F1000 Factor 6.0

Confirmation
 Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy.
Li X, Lewis MT, …, Rosen J, Chang JC
J Natl Cancer Inst 2008 May 7 100(9):672-9 [abstract on PubMed] [related articles] [FREE full text]
Selected by | Ruth Keri
Evaluated 15 Jul 2008

Recommended
F1000 Factor 3.0

New Finding
 A phase II study of mifepristone (RU-486) in castration-resistant prostate cancer, with a correlative assessment of androgen-related hormones.
Taplin ME, Manola J, …, Gelmann EP, Balk SP
BJU Int 2008 May 101(9):1084-9 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Irving Spitz
Evaluated 14 Jul 2008

Recommended
F1000 Factor 3.0

Confirmation
 Dose to the Contralateral Breast from Radiotherapy and Risk of Second Primary Breast Cancer in the WECARE Study.
Stovall M, Smith SA, …, Bernstein JL, WECARE Study Collaborative Group
Int J Radiat Oncol Biol Phys 2008 Jun 13 [abstract on PubMed] [related articles] [full text]
Selected by | Marc Bollet
Evaluated 3 Jul 2008


top of pagePage 1 of 6. Select Page: 1 2 3 4 5 6 >>
Display 10 / 20 / 50 papers per page

© 2008 Medicine Reports Ltd unless otherwise stated < info@f1000.com >   Terms and conditions   Legal info